Delivery Order SPE2DB22D2206-SPE2DB23FJE82
Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $48
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,255 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.01% Estrace cream. As the prime contractor, Amerisourcebergen will supply 42.5 grams of the prescribed medication to the DLA for use in supporting the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period in early September 2023. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency Troop Support Medical awarded a $3,764.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.01% Estrace cream in 42.5 gram containers. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning August 31, 2023 through September 1, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $140,000 to Amerisourcebergen Drug Corporation for the supply of Estrace 0.01% cream. As the prime contractor, Amerisourcebergen will deliver 42.5 grams of the specified medication to its place of performance in Conshohocken, Pennsylvania by the end date of August 29, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics...
- The Defense Logistics Agency awarded a delivery order valued at $1,418.19 to AmerisourceBergen Drug Corp for Estrace 0.01% cream (42.5 grams) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's status as a child contract under the company's broader Indefinite...
- The Defense Logistics Agency awarded a $1,471.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561741371 ESTRACE 0.01% CREAM 42.5GM. The place of performance is Conshohocken, Pennsylvania. The period of performance is August 8-9, 2023. The Defense Logistics Agency supports military readiness by procuring, managing and distributing medical supplies and pharmaceuticals to military treatment facilities worldwide. No major subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $1,056 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.01% Estrace cream. As the prime contractor, Amerisourcebergen will supply 42.5 grams of the prescribed medication to the DLA for use in its medical logistics programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. The parent company, Amerisourcebergen Corporation, will support delivery through its...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at approximately $630 to Amerisourcebergen Drug Corporation for Estrace 0.01% cream in 42.5 gram quantities. Performance will take place in Conshohocken, Pennsylvania under a one-day period from July 17-18, 2023. No additional details were provided regarding the original solicitation or whether this delivery order falls under a larger indefinite-delivery/indefinite-quantity contract vehicle. As...
- <p>Defense Logistics Agency awarded a $722 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for ESTRACE 0.01% cream in 42.5 gram quantities. Performance will occur in Conshohocken, Pennsylvania with all items to be delivered by September 29, 2023. No set-aside designation was used for this sole-source award in support of the Defense Logistics Agency's medical logistics programs.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Estrace 0.01% Cream in a 42.5-gram quantity, with a ceiling value of $1,410.90. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by October 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp on October 12, 2023. The $580 firm fixed price order is for Estrace 0.01% cream supplied in 42.5 gram containers. Performance will occur in Conshohocken, Pennsylvania with an expected completion date of October 13, 2023. As no set-aside designation was used, this represents an open market procurement. Amerisourcebergen Drug Corp is a division of Amerisourcebergen...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJE82Delivery Order
The Defense Logistics Agency awarded a $48,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Estrace 0.01% cream in 42.5 gram quantities. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility in support of the Defense Logistics Agency's medical supply chain programs. No subcontractors or set aside designations were identified. The single order is for a three day period beginning July 14, 2023 under an existing DLA pharmaceutical supply vehicle.
Generated 12/19/23, 9:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48 | 7/14/23 |